Creative Planning Pfizer Inc Call Options Transaction History

Creative Planning

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $32,507 - $37,611	-900 Reduced 90.0%	100 $3,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $39,390 - $51,280	1,000 New	1,000 $40,000
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $103,819 - $117,087	-3,100 Reduced 93.94%	200 $0
Q4 2020 Jan 29, 2021	BUY	$33.47 - $42.56 $43,511 - $55,328	1,300 Added 65.0%	3,300 $1,000
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $47,625 - $55,875	1,500 Added 300.0%	2,000 $5,000

Q2 2020 Jul 23, 2020	SELL	$30.12 - $36.54 $135,540 - $164,430	-4,500 Reduced 90.0%	500 $0
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $172,350 - $209,050	5,000 New	5,000 $48,000

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.